Early Cancer Detection Driving Growth Of DNA And Gene Chip Market Driving Market Acceleration in the DNA And Gene Chip Industry, 2025

Stay ahead with our updated market reports featuring the latest on tariffs, trade flows, and supply chain transformations.

How Large Will the DNA And Gene Chip Market Size By 2025?
In recent times, there has been a significant increase in the size of the DNA and gene chip market. The market is projected to expand from a value of $8.19 billion in 2024 to around $9.27 billion in 2025, registering a compound annual growth rate (CAGR) of 13.1%. Various factors contributing to this growth during the historical period include advancements in genomic research, the proliferation of personalized medicine, achievements related to the human genome project, progressions in drug discovery, and developments in disease biomarker identification.

How Big Is the DNA And Gene Chip Market Size Expected to Grow by 2029?
The market size for DNA and gene chips is predicted to experience a swift expansion in the coming years, reaching $15.35 billion in 2029 with a compound annual growth rate (CAGR) of 13.4%. Various factors can be attributed to this growth during the forecast period, namely, advancements in precision medicine, growth in personalized therapeutics, expanding biomarker discovery, application in oncology research, and increased research funding. The observable trends for the forecast period comprise technological developments, product innovation, regulatory compliance and frameworks, concentration on rare diseases, and continuous cost reduction.

View the full report here:
https://www.thebusinessresearchcompany.com/report/dna-and-gene-chip-global-market-report

Which Key Market Drivers Powering DNA And Gene Chip Market Expansion and Growth?
The DNA and gene market is experiencing significant growth, largely due to the increased need for early cancer detection. Cancer encompasses a range of conditions characterized by abnormal cells multiplying erratically, disturbing normal cell boundaries to infiltrate neighboring organs, and metastasizing to other parts of the body. DNA and gene chips play a crucial role in analyzing gene expression patterns, identifying genetic and epigenetic territories, and determining genomic regulatory elements affected by cancer transcription factors in affected cells. As per the American Cancer Society, a community-based voluntary health organization situated in the US, around 1.9 million new cancer cases and 609,360 cancer-related deaths are anticipated in the country in 2022. Hence, the surging demand for early cancer detection acts as a key driver for the expansion of the DNA and gene chip market.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=8205&type=smp

Which Fast-Growing Trends Are Poised to Disrupt the DNA And Gene Chip Market?
The emergence of strategic collaborations and partnerships is a significant pattern noted in the DNA and gene chip industry. Numerous companies in this field are pursuing alliances to fortify their standing in the market. Avesthagen Limited, an integrated systems biology platform organization based in India, exemplified this trend when they teamed up with Wipro Limited, an Indian IT company, for a four-year agreement in June 2022. Their collaboration focuses on a project called Cancer Risk Assessed by NGS profiling of circulating free DNA and RNA for lung genome sequencing services related to cancer. Furthermore, Thermo Fisher Scientific, an American analytical tools supplier, initiated a partnership with Qatar Genome Program (QGP), a branch of Qatar Foundation (QF), in May 2022. Together, they intend to create an Axiom custom genotyping array for pan-Arab populations using whole genome sequencing data collected from 19 Arab nations. This 800,000 variant array is designed to advance genomic research on ailments like diabetes, cardiovascular disorders, autism, and cancer, benefitting Qatar's national health improvement and precision medicine advancement vision, particularly for Arab identity holders globally. Thermo Fisher's Axiom microarray technology expedites precision medicine initiatives.

What Are the Emerging Segments in the DNA And Gene Chip Market?
The DNA and gene chip market covered in this report is segmented -

1) By Type: Oligonucleotide DNA (o-DNA), Complementary DNA (c-DNA), Other Types
2) By Application: Cancer Diagnostics, Gene Expression, Proteomics, Genomics, Drug Discovery, Agrigenomics, Other Applications
3) By End User: Academic And Government Research Institutes, Biotechnology And Pharmaceutical Companies, Hospitals And Diagnostics Centers, Other End Users

Subsegments:
1) By Oligonucleotide DNA (o-DNA): Custom Oligonucleotide Chips, Commercial Oligonucleotide Arrays
2) By Complementary DNA (c-DNA): cDNA Microarrays, cDNA Expression Arrays
3) By Other Types: Single-Cell RNA Sequencing Chips, SNP (Single Nucleotide Polymorphism) Chips, Whole Genome Amplification Chips

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=8205&type=smp

Who Are the Global Leaders in the DNA And Gene Chip Market?
Major companies operating in the DNA and gene chip market are PerkinElmer Inc., Illumina Inc., Thermo Fisher Scientific Inc., Macrogen Inc., Agilent Technologies Inc., Greiner Bio-One International GmbH, CapitalBio Corporation, Microarrays Inc., bioMérieux SA, Applied Microarrays Inc., Biometrix Technology Inc., Oxford Gene Technology IP Limited, Bioneer Corporation, Eurofins MWG Operon LLC, F. Hoffmann-La Roche Ltd, QIAGEN N.V., Bio-Rad Laboratories Inc., BioChain Institute Inc., Cepheid, Eppendorf AG, Fluidigm Corporation, GE Healare, Genisphere LLC, Gyros Protein Technologies AB, Hitachi High-Technologies Corporation, LC Sciences

Which are the Top Profitable Regional Markets for the DNA And Gene Chip Industry?
North America was the largest region in the DNA and gene chip market share in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the DNA and gene chip market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase the full report:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=8205

This Report Supports:
1. Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2. Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3. Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4. Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.